Pharmaids Pharma Financials
BSE: 524572
₹29.50
₹-0.81
(-2.67%)
As on 08-Sep-2026 16:01IST
Market cap
₹111 Cr
Revenue (TTM)
₹25 Cr
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
25.34
|
27.88
|
19.45
|
15.11
|
--
|
3.94
|
|
|
|
|
|
|
Total Income
|
25.79
|
28.17
|
19.55
|
15.99
|
--
|
3.95
|
|
|
|
|
|
|
Total Expenditure
|
34.25
|
41.39
|
32.19
|
27.49
|
9.89
|
3.80
|
|
|
|
|
|
|
EBITDA
|
-8.91
|
-13.51
|
-12.75
|
-12.38
|
-9.89
|
0.14
|
|
|
|
|
|
|
Depreciation
|
1.91
|
2.03
|
2.44
|
1.72
|
0.02
|
0.01
|
|
|
|
|
|
|
EBIT
|
-10.82
|
-15.54
|
-15.19
|
-14.10
|
-9.90
|
0.13
|
|
|
|
|
|
|
Interest
|
3.05
|
3.52
|
2.10
|
1.58
|
0.00
|
0.00
|
|
|
|
|
|
|
Other Income
|
0.45
|
0.29
|
0.10
|
0.88
|
--
|
0.02
|
|
|
|
|
|
|
Exceptional Items
|
6.70
|
2.46
|
-0.10
|
-0.82
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
-6.72
|
-16.30
|
-17.28
|
-15.62
|
-9.91
|
0.14
|
|
|
|
|
|
|
Provision for Tax
|
-2.33
|
-4.73
|
-3.77
|
-3.78
|
-2.35
|
0.00
|
|
|
|
|
|
|
Profit after Tax
|
-4.39
|
-11.57
|
-13.51
|
-11.84
|
-7.56
|
0.15
|
|
|
|
|
|
|
Minority Interest
|
-0.18
|
-0.15
|
2.73
|
3.88
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
-4.56
|
-11.72
|
-10.78
|
-7.97
|
-7.56
|
0.15
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
47.65
|
47.65
|
59.32
|
72.05
|
22.46
|
8.67
|
|
|
|
|
|
|
Minority Interest
|
-0.18
|
-0.05
|
-4.28
|
-1.55
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
15.65
|
3.37
|
25.59
|
2.60
|
-2.71
|
-0.36
|
|
|
|
|
|
|
Current Liabilities
|
24.01
|
24.01
|
28.71
|
11.58
|
2.12
|
2.44
|
|
|
|
|
|
|
Total Liabilities
|
87.26
|
87.26
|
119.85
|
91.34
|
24.58
|
11.11
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
70.05
|
63.99
|
88.36
|
71.14
|
3.44
|
8.09
|
|
|
|
|
|
|
Current Assets
|
10.99
|
10.99
|
20.99
|
13.53
|
18.32
|
2.67
|
|
|
|
|
|
|
Total Assets
|
87.26
|
87.26
|
119.85
|
91.34
|
24.58
|
11.11
|
|
|
|
|
|
|
Total Debt*
|
--
|
20.91
|
35.25
|
5.35
|
--
|
--
|
|
|
|
|
|
|
Net Current Assets
|
-13.02
|
-13.02
|
-7.73
|
1.96
|
16.19
|
0.23
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-4.06
|
-15.11
|
-10.62
|
-4.02
|
-0.26
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
23.34
|
-12.22
|
-74.99
|
-4.94
|
0.47
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-19.97
|
23.36
|
77.66
|
21.31
|
--
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-0.69
|
-3.98
|
-7.95
|
12.35
|
0.21
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-2.86
|
-3.32
|
-3.06
|
-2.26
|
-3.52
|
0.14
|
|
|
|
|
|
|
Cash EPS (₹)
|
-1.29
|
-2.71
|
-3.14
|
-2.87
|
-3.52
|
0.15
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
14.04
|
13.51
|
16.82
|
20.43
|
10.26
|
8.44
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
-1.15
|
-4.29
|
-3.01
|
-1.87
|
-0.25
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-1.15
|
-7.41
|
-9.03
|
-1.57
|
-0.25
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-15.67
|
-17.65
|
-28.16
|
-63.88
|
1.65
|
|
|
|
|
|
|
ROE (%)
|
-20.22
|
-21.64
|
-20.56
|
-25.19
|
-49.28
|
1.67
|
|
|
|
|
|
|
ROA (%)
|
-4.24
|
-12.56
|
-13.92
|
-22.23
|
-46.31
|
1.35
|
|
|
|
|
|
|
EBIT Margin (%)
|
-42.69
|
-55.73
|
-78.09
|
-93.33
|
--
|
3.25
|
|
|
|
|
|
|
Net Margin (%)
|
-17.02
|
-41.08
|
-69.07
|
-74.06
|
--
|
3.67
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
0.00
|
-34.23
|
-56.90
|
-66.95
|
--
|
3.92
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
18.52
|
43.37
|
28.69
|
--
|
-100.00
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
36.70
|
-2.33
|
-7.67
|
-42.40
|
-7,844.23
|
--
|
|
|
|
|
|
|
Net Profit Growth (%)
|
6.16
|
14.31
|
-14.03
|
-56.74
|
-5,305.69
|
--
|
|
|
|
|
|
|
EPS Growth (%)
|
60.70
|
-8.73
|
-35.25
|
35.88
|
-2,593.63
|
--
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
-19.67
|
-17.66
|
227.60
|
153.62
|
--
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
-10.62
|
--
|
--
|
--
|
--
|
88.51
|
|
|
|
|
|
|
Price / Book Value
|
2.24
|
2.05
|
4.08
|
2.55
|
2.13
|
1.48
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
-15.53
|
-8.95
|
-21.88
|
-15.99
|
-3.44
|
81.73
|
|
|
|
|
|
|
Close Price (₹)
|
38.97
|
27.67
|
68.67
|
52.00
|
21.81
|
12.51
|
|
|
|
|
|
|
High Price (₹)
|
70.00
|
73.45
|
87.46
|
79.23
|
32.45
|
30.40
|
|
|
|
|
|
|
Low Price (₹)
|
25.60
|
27.10
|
31.90
|
19.69
|
10.17
|
10.27
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
110.71
|
97.59
|
242.18
|
183.39
|
--
|
12.85
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.25
|
0.44
|
0.59
|
0.07
|
--
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.19
|
0.09
|
0.02
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
0.46
|
0.46
|
0.73
|
1.17
|
8.62
|
1.09
|
|
|
|
|
|
|
Quick Ratio
|
0.44
|
0.44
|
0.31
|
0.86
|
8.62
|
0.73
|
|
|
|
|
|
|
Interest Coverage
|
-1.20
|
-3.63
|
-7.23
|
-8.90
|
-3,001.33
|
52.27
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
13.53
|
12.30
|
16.09
|
17.73
|
--
|
33.98
|
|
|
|
|
|
|
Asset Turnover
|
0.24
|
0.30
|
0.20
|
0.28
|
--
|
0.37
|
|
|
|
|
|
|
Receivable days
|
--
|
42.92
|
54.50
|
57.16
|
--
|
124.04
|
|
|
|
|
|
|
Inventory Days
|
--
|
82.44
|
148.04
|
86.74
|
--
|
82.25
|
|
|
|
|
|
|
Payable days
|
--
|
203.23
|
305.00
|
111.37
|
861.27
|
235.65
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-77.87
|
-102.46
|
32.53
|
--
|
-29.36
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
